- Home
- ARBE vs ATRA Comparison
ARBE vs ATRA Comparison
Compare ARBE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBE | ATRA |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.9M | 129.4M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ARBE | ATRA |
|---|---|---|
| Price | $1.17 | $18.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.75 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 3.1M | 75.8K |
| Earning Date | 11-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | $667,000.00 | ★ $151,930,000.00 |
| Revenue This Year | $69.79 | N/A |
| Revenue Next Year | $576.46 | N/A |
| P/E Ratio | ★ N/A | $9.20 |
| Revenue Growth | N/A | ★ 51.27 |
| 52 Week Low | $0.85 | $5.01 |
| 52 Week High | $5.09 | $18.95 |
Technical Indicators
Market Signals| Indicator | ARBE | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 63.35 |
| Support Level | $1.12 | $16.59 |
| Resistance Level | $1.27 | $18.30 |
| Average True Range (ATR) | 0.09 | 1.24 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 46.52 | 67.06 |
Price Performance
Historical ComparisonAbout ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).